Eitan Amir
Eitan Amir
Princess Margaret Cancer Centre
Потвърден имейл адрес: uhn.ca
Заглавие
Позовавания
Позовавания
Година
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
AJ Templeton, MG McNamara, B Šeruga, FE Vera-Badillo, P Aneja, ...
Journal of the National Cancer Institute 106 (6), dju124, 2014
13162014
Delivering affordable cancer care in high-income countries
R Sullivan, J Peppercorn, K Sikora, J Zalcberg, NJ Meropol, E Amir, ...
The lancet oncology 12 (10), 933-980, 2011
6302011
Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis
AM Horgan, E Amir, T Walter, JJ Knox
J Clin Oncol 30 (16), 1934-1940, 2012
4782012
Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis
E Amir, B Seruga, S Niraula, L Carlsson, A Ocaña
Journal of the National Cancer Institute 103 (17), 1299-1309, 2011
4642011
Assessing women at high risk of breast cancer: a review of risk assessment models
E Amir, OC Freedman, B Seruga, DG Evans
JNCI: Journal of the National Cancer Institute 102 (10), 680-691, 2010
4302010
Prospective study evaluating the impact of tissue confirmation of metastatic disease in patients with breast cancer
E Amir, N Miller, W Geddie, O Freedman, F Kassam, C Simmons, ...
Journal of clinical oncology 30 (6), 587, 2012
3912012
Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis
AJ Templeton, O Ace, MG McNamara, M Al-Mubarak, FE Vera-Badillo, ...
Cancer Epidemiology and Prevention Biomarkers, 2014
3542014
Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme
E Amir, DG Evans, A Shenton, F Lalloo, A Moran, C Boggis, M Wilson, ...
Journal of medical genetics 40 (11), 807-814, 2003
3162003
Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme
E Amir, DG Evans, A Shenton, F Lalloo, A Moran, C Boggis, M Wilson, ...
Journal of medical genetics 40 (11), 807-814, 2003
3162003
A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO
DGR Evans, DM Eccles, N Rahman, K Young, M Bulman, E Amir, ...
Journal of medical genetics 41 (6), 474-480, 2004
2592004
Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis
FE Vera-Badillo, AJ Templeton, P de Gouveia, I Diaz-Padilla, PL Bedard, ...
Journal of the National Cancer Institute 106 (1), djt319, 2014
2532014
Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy
JM Hou, A Greystoke, L Lancashire, J Cummings, T Ward, R Board, ...
The American journal of pathology 175 (2), 808-816, 2009
2352009
PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer
F Dupuy, S Tabariès, S Andrzejewski, Z Dong, J Blagih, MG Annis, ...
Cell Metabolism 22 (4), 577-589, 2015
2262015
Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis
JL Ethier, D Desautels, A Templeton, PS Shah, E Amir
Breast Cancer Research 19 (1), 1-13, 2017
1752017
The price we pay for progress: a meta-analysis of harms of newly approved anticancer drugs
S Niraula, B Seruga, A Ocana, T Shao, R Goldstein, IF Tannock, E Amir
Journal of Clinical Oncology 30 (24), 3012-3019, 2012
1652012
HER3 overexpression and survival in solid tumors: a meta-analysis
A Ocana, F Vera-Badillo, B Seruga, A Templeton, A Pandiella, E Amir
JNCI: Journal of the National Cancer Institute 105 (4), 266-273, 2013
1612013
Tissue confirmation of disease recurrence in breast cancer patients: pooled analysis of multi-centre, multi-disciplinary prospective studies
E Amir, M Clemons, CA Purdie, N Miller, P Quinlan, W Geddie, ...
Cancer treatment reviews 38 (6), 708-714, 2012
1522012
Biosimilars of biological drug therapies
G Dranitsaris, E Amir, K Dorward
Drugs 71 (12), 1527-1536, 2011
1512011
HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer
TA Barnes, E Amir
British journal of cancer 117 (4), 451-460, 2017
1232017
Activation of the PI3K/mTOR/AKT Pathway and Survival in Solid Tumors: Systematic Review and Meta-Analysis
A Ocana, F Vera-Badillo, M Al-Mubarak, AJ Templeton, ...
PloS one 9 (4), e95219, 2014
1222014
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20